LIVE on April 23rd: Has Covid impacted India's long-term growth potential?
Here is the latest financial fact sheet of SHASUN PHARMA. For more details, see the SHASUN PHARMA quarterly results and SHASUN PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | 5.5 |
No. of shares | m | 60.10 |
% ch week | % | 11.9 |
% ch 1-mth | % | 7.4 |
% ch 12-mth | % | 102.2 |
52 week H/L | Rs | 432.1/211.6 |
No. of Mths Year Ending |
12 Mar-10* |
12 Mar-11* |
12 Mar-12* |
12 Mar-13* |
12 Mar-14* |
5-Yr Chart Click to enlarge
|
---|
SHASUN PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 54 | 101 | 92 | 186 | 94 | |
Low | Rs | 12 | 49 | 38 | 60 | 46 | |
Sales per share (Unadj.) | Rs | 158.4 | 171.9 | 193.5 | 191.6 | 214.2 | |
Earnings per share (Unadj.) | Rs | 0.8 | -2.9 | 18.2 | 9.4 | 5.3 | |
Diluted earnings per share | Rs | 0.6 | -2.4 | 16.7 | 8.8 | 5.0 | |
Cash flow per share (Unadj.) | Rs | 8.6 | 4.8 | 25.6 | 18.7 | 15.8 | |
Dividends per share (Unadj.) | Rs | 1.00 | 0.30 | 2.40 | 1.50 | 1.00 | |
Adj. dividends per share | Rs | 0.80 | 0.24 | 2.20 | 1.41 | 0.94 | |
Dividend yield (eoy) | % | 3.0 | 0.4 | 3.7 | 1.2 | 1.4 | |
Book value per share (Unadj.) | Rs | 24.4 | 17.3 | 40.2 | 47.7 | 53.3 | |
Adj. book value per share | Rs | 19.6 | 14.0 | 36.8 | 44.9 | 50.3 | |
Shares outstanding (eoy) | m | 48.31 | 48.54 | 55.12 | 56.62 | 56.62 | |
Bonus/Rights/Conversions | - | ESOP | PI | PI | - | ||
Price / Sales ratio | x | 0.2 | 0.4 | 0.3 | 0.6 | 0.3 | |
Avg P/E ratio | x | 42.4 | -25.8 | 3.6 | 13.1 | 13.1 | |
P/CF ratio (eoy) | x | 3.8 | 15.5 | 2.5 | 6.6 | 4.4 | |
Price / Book Value ratio | x | 1.4 | 4.3 | 1.6 | 2.6 | 1.3 | |
Dividend payout | % | 128.5 | -10.3 | 13.2 | 16.0 | 18.7 | |
Avg Mkt Cap | Rs m | 1,594 | 3,641 | 3,583 | 6,964 | 3,958 | |
No. of employees | `000 | 1.5 | NA | 1.5 | NA | NA | |
Total wages/salary | Rs m | 1,403 | 1,432 | 1,594 | 1,866 | 2,164 | |
Avg. sales/employee | Rs Th | 5,278.9 | NM | 7,109.3 | NM | NM | |
Avg. wages/employee | Rs Th | 967.7 | NM | 1,062.7 | NM | NM | |
Avg. net profit/employee | Rs Th | 25.9 | NM | 670.5 | NM | NM |
SHASUN PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 7,654 | 8,345 | 10,664 | 10,848 | 12,127 | |
Other income | Rs m | 221 | 220 | 130 | 183 | 229 | |
Total revenues | Rs m | 7,875 | 8,564 | 10,794 | 11,030 | 12,356 | |
Gross profit | Rs m | 292 | 715 | 1,230 | 1,102 | 1,009 | |
Depreciation | Rs m | 379 | 376 | 406 | 527 | 594 | |
Interest | Rs m | 301 | 323 | 437 | 255 | 415 | |
Profit before tax | Rs m | -167 | 236 | 517 | 504 | 230 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | -408 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 187 | 0 | 280 | 0 | 0 | |
Tax | Rs m | -18 | -30 | -209 | -26 | -73 | |
Profit after tax | Rs m | 38 | -141 | 1,006 | 530 | 302 | |
Gross profit margin | % | 3.8 | 8.6 | 11.5 | 10.2 | 8.3 | |
Effective tax rate | % | 10.5 | -12.8 | -40.5 | -5.2 | -31.7 | |
Net profit margin | % | 0.5 | -1.7 | 9.4 | 4.9 | 2.5 |
SHASUN PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 3,886 | 3,725 | 4,792 | 5,312 | 6,884 | |
Current liabilities | Rs m | 2,076 | 4,746 | 5,545 | 6,491 | 8,456 | |
Net working cap to sales | % | 23.6 | -12.2 | -7.1 | -10.9 | -13.0 | |
Current ratio | x | 1.9 | 0.8 | 0.9 | 0.8 | 0.8 | |
Inventory Days | Days | 45 | 56 | 47 | 57 | 62 | |
Debtors Days | Days | 92 | 69 | 79 | 89 | 108 | |
Net fixed assets | Rs m | 2,746 | 2,604 | 3,308 | 4,456 | 4,970 | |
Share capital | Rs m | 97 | 97 | 110 | 113 | 113 | |
"Free" reserves | Rs m | 907 | 739 | 2,082 | 2,605 | 2,875 | |
Net worth | Rs m | 1,178 | 839 | 2,213 | 2,700 | 3,020 | |
Long term debt | Rs m | 3,264 | 672 | 779 | 1,183 | 1,817 | |
Total assets | Rs m | 6,635 | 6,545 | 8,605 | 10,445 | 13,347 | |
Interest coverage | x | 0.4 | 1.7 | 2.2 | 3.0 | 1.6 | |
Debt to equity ratio | x | 2.8 | 0.8 | 0.4 | 0.4 | 0.6 | |
Sales to assets ratio | x | 1.2 | 1.3 | 1.2 | 1.0 | 0.9 | |
Return on assets | % | 5.1 | 2.8 | 16.8 | 7.5 | 5.4 | |
Return on equity | % | 3.2 | -16.8 | 45.4 | 19.6 | 10.0 | |
Return on capital | % | 7.2 | 10.0 | 41.2 | 19.5 | 13.3 | |
Exports to sales | % | 40.6 | 46.8 | 46.7 | 47.0 | 46.4 | |
Imports to sales | % | 10.8 | 13.7 | 14.4 | 13.7 | 14.2 | |
Exports (fob) | Rs m | 3,107 | 3,902 | 4,982 | 5,101 | 5,622 | |
Imports (cif) | Rs m | 826 | 1,147 | 1,535 | 1,484 | 1,728 | |
Fx inflow | Rs m | 3,283 | 4,011 | 5,083 | 5,258 | 5,843 | |
Fx outflow | Rs m | 828 | 1,344 | 1,791 | 1,707 | 2,173 | |
Net fx | Rs m | 2,454 | 2,667 | 3,292 | 3,552 | 3,669 |
SHASUN PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 370 | 590 | 508 | 349 | 398 | |
From Investments | Rs m | 96 | -321 | -773 | -1,611 | -1,635 | |
From Financial Activity | Rs m | -398 | -279 | 316 | 1,172 | 1,309 | |
Net Cashflow | Rs m | 68 | -10 | 52 | -90 | 71 |
Share Holding
|
Company Information
|
CHM: R. Kannan | COMP SEC: S. Murali Krishna | YEAR OF INC: 1976 | BSE CODE: 524552 | FV (Rs): 2 | DIV YIELD (%): 0.2 |
More Pharmaceuticals Company Fact Sheets: ORCHID PHARMA LUPIN FDC SANOFI INDIA JUBILANT PHARMOVA
Compare SHASUN PHARMA With: ORCHID PHARMA LUPIN FDC SANOFI INDIA JUBILANT PHARMOVA
Compare SHASUN PHARMA With: MYLAN (US) ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Indian share markets ended on a positive note yesterday. At the closing bell yesterday, the BSE Sensex stood higher by 375 points (up 0.8%).
Ajit Dayal on how India's vaccine strategy will impact the markets.
In this video I tell you the three Nifty ETFs I think are the best.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
There is no stopping this 11-bagger stock from significant upside.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
More